Sentrian, Remote Patient Intelligence
Come visit us at Booth 1329!
Sentrian™, the Remote Patient Intelligence® company, aspires to eliminate all preventable hospitalization by leveraging the revolution in remote biosensors and machine learning to detect patient deterioration early, before it becomes acute. Sentrian’s value proposition to health care organizations is to provide a cloud-based remote patient monitoring and analytics platform proven to remotely detect health deterioration predictive of hospitalization at more than double the accuracy of first generation monitoring. The Sentrian platform is commercially available, FDA cleared and designed to seamlessly integrate with existing healthcare information systems and clinical workflows, facilitating adoption. Sentrian is the sole winner of the American Telemedicine Association’s 2015 President’s Award for Innovation in Remote Health Care and the Winner of the Frost and Sullivan Technology Innovation Award for Remote Patient Monitoring. Find us at www.sentrian.com, on Twitter and LinkedIn.
Brands: The Essential Intelligence for Remote Patient Monitoring.